Acellus Biotech helps international and emerging biotechnology companies establish and grow their U.S. commercial presence. We connect technical understanding with disciplined business development.
You may need a U.S. commercial lead before you need a full sales organization. Acellus provides that bridge, with a model designed to evolve as your business grows.
Our work goes beyond individual sales conversations. We help establish account strategy, pipeline practices, commercial processes, and team structure that remain useful after our engagement.
M.S. · Molecular Biology
Based in South Carolina, serving U.S. accounts nationwide.
Morgan brings more than a decade of experience across life-science business development, laboratory science, and education. That combination informs an approach built around understanding the technology, earning the buyer’s confidence, and following through commercially.
I've spent my career on both sides of the bench, and I love helping strong science find the people who need it.
Previous commercial roles at Infinity Bio, Synbio Technologies, Abiosciences, GenScript, and Evotec span molecular diagnostics, gene and oligonucleotide synthesis, peptides, proteins, antibodies, and genomics.
Organizations listed describe Morgan’s prior experience; they are not presented as Acellus clients or endorsers.
Experience managing prospecting, technical discovery, proposals, quote follow-up, negotiation, and pipeline forecasting for scientific services.
Founder experience includes hiring, training, pricing, and building an independently operated education and agritourism business.
Collegiate biology teaching and hands-on laboratory work support clear conversations with research teams and senior scientific buyers.
No. Acellus can begin as your outsourced U.S. commercial lead, helping establish target accounts, outreach, pipeline discipline, and sales processes before you build a permanent team.
Yes. The starting point depends on your current market presence and priorities. An engagement may focus on market entry, business development, team buildout, or fractional leadership. Scope is agreed before work begins.
The first conversation can focus on non-confidential capabilities, buyer segments, and commercial goals. Confidential technical details and appropriate information-sharing arrangements can be addressed separately.
The engagement is designed around eventual client ownership. Processes, account context, opportunity information, and team responsibilities are documented and transferred as part of the agreed handoff.
Timing and fees depend on the scope, technical offering, market priorities, and level of commercial support required. These are discussed during discovery and defined in an engagement proposal.
Tell us about your technology, your ambitions,
and where you are today.
